Gilead Sciences (GILD) Debt to Equity Ratio
Current and historical debt to equity ratio values for Gilead Sciences (GILD) over the last 10 years.
|Medical||Medical - Biomedical and Genetics||$94.718B||$30.390B|
|Gilead Sciences, Inc. is an independent biopharmaceutical company that seeks to provide accelerated solutions for patients and the people who care for them. They have a broad-based focus on developing and marketing drugs to treat patients with infectious diseases, including viral infections, fungal infections and bacterial infections, and a specialized focus on cancer. They have expertise in liposomal drug delivery technology, a technology that the company uses to develop drugsthat are safer, easier for patients to tolerate and more effective.|